Transcriptional regulators in mammary gland development and cancer

International Journal of Biochemistry and Cell Biology

Volumn 35, Issue 7, 2003, Pages 1034-1051

  Visvader, Jane E ^a   Lindeman, Geoffrey J ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Breast cancer; Mammary gland development; Transcription factors

Indexed keywords

BETA CATENIN; ESTROGEN RECEPTOR ALPHA; HELIX LOOP HELIX PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; HOMEODOMAIN PROTEIN; LEUCINE ZIPPER PROTEIN; LYMPHOID ENHANCER FACTOR 1; MYC PROTEIN; NUCLEAR RECEPTOR COACTIVATOR 2; PROGESTERONE RECEPTOR; PROTEIN P53; STAT3 PROTEIN; STAT5A PROTEIN; STAT5B PROTEIN; STEROID RECEPTOR COACTIVATOR 1; STEROID RECEPTOR COACTIVATOR 3; TRANSCRIPTION FACTOR ETS 2; TRANSCRIPTION FACTOR HOXA9; TRANSCRIPTION FACTOR HOXB9; TRANSCRIPTION FACTOR HOXC6; TRANSCRIPTION FACTOR HOXD10; TRANSCRIPTION FACTOR HOXD9; TRANSCRIPTION FACTOR HSIX1; TRANSCRIPTION FACTOR MSX1; TRANSCRIPTION FACTOR MSX2; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

BREAST CARCINOGENESIS; BREAST DEVELOPMENT; CANCER GENETICS; EMBRYO DEVELOPMENT; GENE OVEREXPRESSION; HUMAN; INVOLUTION; LACTATION; MAMMARY GLAND FUNCTION; NONHUMAN; PREGNANCY; PROTEIN FUNCTION; PUBERTY; REVIEW; TRANSCRIPTION REGULATION;

EID: 0037411179     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(03)00030-X     Document Type: Review

References (106)

1. Anzick S.L., Kononen J., Walker R.L., Azorsa D.O., Tanner M.M., Guan X.Y., Sauter G., Kallioniemi O.P., Trent J.M., Meltzer P.S. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science. 277:1997;965-968.
2. Barker N., Huls G., Korinek V., Clevers H. Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium. American Journal of Pathology. 154:1999;29-35.
3. Bautista S., Valles H., Walker R.L., Anzick S., Zeillinger R., Meltzer P., Theillet C. In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity. Clinical Cancer Research. 4:1998;2925-2929.
4. Benezra R., Davis R.L., Lockshon D., Turner D.L., Weintraub H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell. 61:1990;49-59.
5. Berns E.M., Klijn J.G., van Putten W.L., van Staveren I.L., Portengen H., Foekens J.A. c-myc amplification is a better prognostic factor than Her-2/neu amplification in primary breast cancer. Cancer Research. 52:1992;1107-1113.
6. Biben C., Palmer S., Elliott D.A., Harvey R.P. Homeobox genes and heart development. Cold Spring Harbour Symposium of Quantitative Biology. 62:1997;395-403.
7. Bowman T., Garcia R., Turkson J., Jove R. Stats in oncogenesis. Oncogene. 19:2000;2474-2488.
8. Brisken C., Park S., Vass T., Lydon J.P., O'Malley B.W., Weinberg R.A. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proceedings of the National Academy of Sciences of United States of America. 95:1998;5076-5081.
9. Brisken C., Heineman A., Chavarria T., Elenbaas B., Tan J., Dey S.K., McMahon J.A., McMahon A.P., Weinberg R.A. Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Development. 14:2000;650-654.
10. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., Darnell J.E. Jr. Stat3 as an oncogene. Cell. 98:1999;295-303.
11. Buckley M.F., Sweeney K.J., Hamilton J.A., Sini R.L., Manning D.L., Nicholson R.I., deFazio A., Watts C.K., Musgrove E.A., Sutherland R.L. Expression and amplification of cyclin genes in human breast cancer. Oncogene. 8:1993;2127-2133.
12. Care A., Silvani A., Meccia E., Mattia G., Peschle C., Colombo M.P. Transduction of the SkBr3 breast carcinoma cell line with the Hoxb7 gene induces bFGF expression, increases cell proliferation and reduces growth factor dependence. Oncogene. 16:1998;3285-3289.
13. Chang C.H., Scott G.K., Kuo W.L., Xiong X., Suzdaltseva Y., Park J.W., Sayre P., Erny K., Collins C., Gray J.W., Benz C.C. ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis. Oncogene. 14:1997;1617-1622.
14. Chapman R.S., Lourenco P.C., Tonner E., Flint D.J., Selbert S., Takeda K., Akira S., Clarke A.R., Watson C.J. Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Development. 13:1999;2604-2616.
15. Chen F., Capecchi M.R. Paralogous mouse Hox genes, Hoxa9, Hoxb9, and Hoxd9, function together to control development of the mammary gland in response to pregnancy. Proceedings of the National Academy of Sciences of United States of America. 96:1999;541-546.
16. Clarke R.B., Howell A., Potten C.S., Anderson E. Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Research. 57:1997;4987-4991.
17. Clevers H., van de Wetering M. TCF/LEF factor earn their wings. Trends Genetics. 13:1997;485-489.
18. Cole M.D., McMahon S.B. The myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene. 18:1999;2916-2924.
19. Conneely O.M., Mulac-Jericevic B., DeMayo F., Lydon J.P., O'Malley B.W. Reproductive functions of progesterone receptors. Recent Program of Hormonal Research. 57:2002;339-355.
20. Cunha G.R., Young P., Christov K., Guzman R., Nandi S., Talamantes F., Thordarson G. Mammary phenotypic expression induced in epidermal cells by embryonic mammary mesenchyme. Acta Anatomy. 152:1995;195-204.
21. Cunha G.R., Young P., Hom Y.K., Cooke P.S., Taylor J.A., Lubahn D.B. Elucidation of a role for stromal steroid hormone receptors in mammary gland growth and development using tissue recombinants. Journal Mammary Gland Biological Neoplasia. 2:1997;393-402.
22. Cuny M., Kramar A., Courjal F., Johannsdottir V., Iacopetta B., Fontaine H., Grenier J., Culine S., Theillet C. Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations. Cancer Research. 60:2000;1077-1083.
23. Dang C.V. c-myc target genes involved in cell growth, apoptosis, and metabolism. Molecular and Cellular Biology. 19:1999;1-11.
24. Darnell J.E. Jr. Stats and gene regulation. Science. 277:1997;1630-1635.
25. Davidson D. The function and evolution of Msx genes: pointers and paradoxes. Trends Genetics. 11:1995;405-411.
26. D'Cruz C.M., Gunther E.J., Boxer R.B., Hartman J.L., Sintasath L., Moody S.E., Cox J.D., Ha S.I., Belka G.K., Golant A., Cardiff R.D., Chodosh L.A. c-myc induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Natural Medicine. 7:2001;235-239.
27. Desprez P.Y., Hara E., Bissell M.J., Campisi J. Suppression of mammary epithelial cell differentiation by the helix-loop-helix protein Id-1. Molecular and Cellular Biology. 15:1995;3398-3404.
28. Desprez P.Y., Lin C.Q., Thomasset N., Sympson C.J., Bissell M.J., Campisi J. A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1. Molecular and Cellular Biology. 18:1998;4577-4588.
29. Dubik D., Shiu R.P. Mechanism of estrogen activation of c-myc oncogene expression. Oncogene. 7:1992;1587-1594.
30. El-Tanani M., Fernig D.G., Barraclough R., Green C., Rudland P. Differential modulation of transcriptional activity of estrogen receptors by direct protein-protein interactions with the T cell factor family of transcription factors. Journal Biological Chemistry. 276:2001;41675-41682.
31. Ford H.L., Kabingu E.N., Bump E.A., Mutter G.L., Pardee A.B. Abrogation of the G2 cell cycle checkpoint associated with overexpression of Hsix1: a possible mechanism of breast carcinogenesis. Proceedings of the National Academy of Sciences of United States of America. 95:1998;12608-12613.
32. Frasor J., Park K., Byers M., Telleria C., Kitamura T., Yu-Lee L.Y., Djiane J., Park-Sarge O.K., Gibori G. Differential roles for signal transducers and activators of transcription 5a and 5b in PRL stimulation of ERalpha and ERbeta transcription. Molecular Endocrinology. 15:2001;2172-2181.
33. Friedmann Y., Daniel C.W. Regulated expression of homeobox genes Msx-1 and Msx-2 in mouse mammary gland development suggests a role in hormone action and epithelial-stromal interactions. Development Biology. 177:1996;347-355.
34. Friedmann Y., Daniel C.A., Strickland P., Daniel C.W. Hox genes in normal and neoplastic mouse mammary gland. Cancer Research. 54:1994;5981-5985.
35. Galang C.K., Garcia-Ramirez J., Solski P.A., Westwick J.K., Der C.J., Neznanov N.N., Oshima R.G., Hauser C.A. Oncogenic Neu/ErbB-2 increases Ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting Ets activation blocks Neu-mediated cellular transformation. Journal Biological Chemistry. 271:1996;7992-7998.
36. Garcia-Gasca A., Spyropoulos D.D. Differential mammary morphogenesis along the anteroposterior axis in Hoxc6 gene targeted mice. Development Dynamics. 219:2000;261-276.
37. Garcia R., Bowman T.L., Niu G., Yu H., Minton S., Muro-Cacho C.A., Cox C.E., Falcone R., Fairclough R., Parsons S., Laudano A., Gazit A., Levitzki A., Kraker A., Jove R. Constitutive activation of Stat3 by the SRC and Jak tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene. 20:2001;2499-2513.
38. Graves B.J., Petersen J.M. Specificity within the Ets family of transcription factors. Advanced Cancer Research. 75:1998;1-55.
39. Grosschedl R., Giese K., Pagel J. HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genetics. 10:1994;94-100.
40. Gruvberger S., Ringner M., Chen Y., Panavally S., Saal L.H., Borg A., Ferno M., Peterson C., Meltzer P.S. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Research. 61:2001;5979-5984.
41. Hennighausen L., Robinson G.W. Think globally, act locally: the making of a mouse mammary gland. Genes Development. 12:1998;449-455.
42. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., Kinzler K.W. Identification of c-myc as a target of the APC pathway. Science. 281:1998;1509-1512.
43. Hu G., Lee H., Price S.M., Shen M.M., Abate-Shen C. Msx homeobox genes inhibit differentiation through upregulation of cyclin D1. Development. 128:2001;2373-2384.
44. Humphreys R.C., Bierie B., Zhao L., Raz R., Levy D., Hennighausen L. Deletion of Stat3 blocks mammary gland involution and extends functional competence of the secretory epithelium in the absence of lactogenic stimuli. Endocrinology. 143:2002;3641-3650.
45. Humphreys R.C., Lydon J., O'Malley B.W., Rosen J.M. Mammary gland development is mediated by both stromal and epithelial progesterone receptors. Molecular Endocrinology. 11:1997;801-811.
46. Hynes N.E., Lane H.A. myc and mammary cancer: myc is a downstream effector of the ErbB2 receptor tyrosine kinase. Journal Mammary Gland Biological Neoplasia. 6:2001;141-150.
47. Ihle J.N. Stats and MAPKs: obligate or opportunistic partners in signaling. Bioessays. 18:1996;95-98.
48. Imagawa, W., Yang, J., Guzman, R., & Nandi, S. (1994). Control of mammary gland development. In E. Knobil & J. D. Neil (Eds.), The Physiology of Reproduction. New York: Raven Press.
49. Jakacka M., Ito M., Martinson F., Ishikawa T., Lee E.J., Jameson J.L. An estrogen receptor (ER)alpha deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo. Molecular Endocrinology. 16:2002;2188-2201.
50. Jamerson M.H., Johnson M.D., Dickson R.B. Dual regulation of proliferation and apoptosis: c-myc in bitransgenic murine mammary tumor models. Oncogene. 19:2000;1065-1071.
51. Kaplan D.H., Shankaran V., Dighe A.S., Stockert E., Aguet M., Old L.J., Schreiber R.D. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proceedings of the National Academy of Sciences of United States of America. 95:1998;7556-7561.
52. Kiuchi N., Nakajima K., Ichiba M., Fukada T., Narimatsu M., Mizuno K., Hibi M., Hirano T. Stat3 is required for the gp130-mediated full activation of the c-myc gene. Journal Experimental Medicine. 189:1999;63-73.
53. Korach K.S., Couse J.F., Curtis S.W., Washburn T.F., Lindzey J., Kimbro K.S., Eddy E.M., Migliaccio S., Snedeker S.M., Lubahn D.B., Schomberg D.W., Smith E.P. Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Program of Hormonal Research. 51:1996;159-186.
54. Lasorella A., Noseda M., Beyna M., Yokota Y., Iavarone A. Id2 is a retinoblastoma protein target and mediates signalling by myc oncoproteins. Nature. 407:2000;592-598.
55. Lewis M.T. Homeobox genes in mammary gland development and neoplasia. Breast Cancer Research. 2:2000;158-169.
56. Lin S.Y., Xia W., Wang J.C., Kwong K.Y., Spohn B., Wen Y., Pestell R.G., Hung M.C. Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proceedings of the National Academy of Sciences of United States of America. 97:2000;4262-4266.
57. Liu X., Robinson G.W., Wagner K.U., Garrett L., Wynshaw-Boris A., Hennighausen L. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Development. 11:1997;179-186.
58. Lydon J.P., DeMayo F.J., Funk C.R., Mani S.K., Hughes A.R., Montgomery C.A. Jr., Shyamala G., Conneely O.M., O'Malley B.W. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Development. 9:1995;2266-2278.
59. Massari M.E., Murre C. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Molecular and Cellular Biology. 20:2000;429-440.
60. Matsumura I., Kitamura T., Wakao H., Tanaka H., Hashimoto K., Albanese C., Downward J., Pestell R.G., Kanakura Y. Transcriptional regulation of the cyclin D1 promoter by Stat5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBO Journal. 18:1999;1367-1377.
61. McDonnell D.P., Norris J.D. Connections and regulation of the human estrogen receptor. Science. 296:2002;1642-1644.
62. Michaelson J.S., Leder P. Beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland. Oncogene. 20:2001;5093-5099.
63. Miyoshi K., Shillingford J.M., Smith G.H., Grimm S.L., Wagner K.U., Oka T., Rosen J.M., Robinson G.W., Hennighausen L. Signal transducer and activator of transcription (Stat5) controls the proliferation and differentiation of mammary alveolar epithelium. Journal of Cellular Biology. 155:2001;531-542.
64. Miyoshi K., Shillingford J.M., Le Provost F., Gounari F., Bronson R., von Boehmer H., Taketo M.M., Cardiff R.D., Hennighausen L., Khazaie K. Activation of beta-catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias. Proceedings of the National Academy of Sciences of United States of America. 99:2002;219-224.
65. Mori S., Nishikawa S.I., Yokota Y. Lactation defect in mice lacking the helix-loop-helix inhibitor Id2. EMBO Journal. 19:2000;5772-5781.
66. Mulac-Jericevic B., Mullinax R.A., DeMayo F.J., Lydon J.P., Conneely O.M. Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science. 289:2000;1751-1754.
67. Nass S.J., Dickson R.B. Defining a role for c-myc in breast tumorigenesis. Breast Cancer Research and Treatment. 44:1997;1-22.
68. Neve R.M., Sutterluty H., Pullen N., Lane H.A., Daly J.M., Krek W., Hynes N.E. Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells. Oncogene. 19:2000;1647-1656.
69. Neznanov N., Man A.K., Yamamoto H., Hauser C.A., Cardiff R.D., Oshima R.G. A single targeted Ets2 allele restricts development of mammary tumors in transgenic mice. Cancer Research. 59:1999;4242-4246.
70. Nilsson S., Makela S., Treuter E., Tujague M., Thomsen J., Andersson G., Enmark E., Pettersson K., Warner M., Gustafsson J.A. Mechanisms of estrogen action. Physiological Review. 81:2001;1535-1565.
71. O'Regan R.M., Jordan V.C. The evolution of tamoxifen therapy in breast cancer: selective oestrogen-receptor modulators and downregulators. Lancet Oncology. 3:2002;207-214.
72. Peifer M., Polakis P. Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science. 287:2000;1606-1609.
73. Peng B., Sutherland K.D., Sum E.Y., Olayioye M., Wittlin S., Tang T.K., Lindeman G.J., Visvader J.E. CPAP is a novel Stat5-interacting cofactor that augments Stat5-mediated transcriptional activity. Molecular Endocrinology. 16:2002;2019-2033.
74. Phippard D.J., Weber-Hall S.J., Sharpe P.T., Naylor M.S., Jayatalake H., Maas R., Woo I., Roberts-Clark D., Francis-West P.H., Liu Y.H., Maxson R., Hill R.E., Dale T.C. Regulation of Msx-1, Msx-2, Bmp-2 and Bmp-4 during foetal and postnatal mammary gland development. Development. 122:1996;2729-2737.
75. Rabbitts T.H. LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes. Genes Developement. 12:1998;2651-2657.
76. Racevskis J., Dill A., Stockert R., Fineberg S.A. Cloning of a novel nucleolar guanosine 5'-triphosphate binding protein autoantigen from a breast tumor. Cell Growth Difference. 7:1996;271-280.
77. Richer J.K., Jacobsen B.M., Manning N.G., Abel M.G., Wolf D.M., Horwitz K.B. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. Journal of Biological Chemistry. 277:2002;5209-5218.
78. Robinson G.W., Johnson P.F., Hennighausen L., Sterneck E. The C/EBPbeta transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland. Genes Development. 12:1998;1907-1916.
79. Sanchez R., Nguyen D., Rocha W., White J.H., Mader S. Diversity in the mechanisms of gene regulation by estrogen receptors. Bioessays. 24:2002;244-254.
80. Sapi E., Flick M.B., Rodov S., Kacinski B.M. Ets-2 transdominant mutant abolishes anchorage-independent growth and macrophage colony-stimulating factor-stimulated invasion by BT20 breast carcinoma cells. Cancer Research. 58:1998;1027-1033.
81. Satokata I., Ma L., Ohshima H., Bei M., Woo I., Nishizawa K., Maeda T., Takano Y., Uchiyama M., Heaney S., Peters H., Tang Z., Maxson R., Maas R. Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Natural Genetics. 24:2000;391-395.
82. Scott G.K., Chang C.H., Erny K.M., Xu F., Fredericks W.J., Rauscher F.J. III, Thor A.D., Benz C.C. Ets regulation of the ErbB2 promoter. Oncogene. 19:2000;6490-6502.
83. Seagroves T.N., Krnacik S., Raught B., Gay J., Burgess-Beusse B., Darlington G.J., Rosen J.M. C/EBPbeta, but not C/EBPalpha, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland. Genes Development. 12:1998;1917-1928.
84. Shang Y., Brown M. Molecular determinants for the tissue specificity of SERMs. Science. 295:2002;2465-2468.
85. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., Ben-Ze'ev A. The cyclin D1 gene is a target of the beta-catenin/LEF1 pathway. Proceedings of the National Academy of Sciences of United States of America. 96:1999;5522-5527.
86. Shuai K. Modulation of Stat signaling by Stat-interacting proteins. Oncogene. 19:2000;2638-2644.
87. Siegel P.M., Hardy W.R., Muller W.J. Mammary gland neoplasia: insights from transgenic mouse models. Bioessays. 22:2000;554-563.
88. Sorlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., Hastie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Thorsen T., Quist H., Matese J.C., Brown P.O., Botstein D., Eystein Lonning P., Borresen-Dale A.L. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proceedings of the National Academy of Sciences of United States of America. 98:2001;10869-10874.
89. Srebrow A., Friedmann Y., Ravanpay A., Daniel C.W., Bissell M.J. Expression of Hoxa-1 and Hoxb-7 is regulated by extracellular matrix-dependent signals in mammary epithelial cells. Journal of Cellular Biochemistry. 69:1998;377-391.
90. Stoecklin E., Wissler M., Moriggl R., Groner B. Specific DNA binding of Stat5, but not of glucocorticoid receptor, is required for their functional cooperation in the regulation of gene transcription. Molecular and Cellular Biology. 17:1997;6708-6716.
91. Sum E.Y., Peng B., Yu X., Chen J., Byrne J., Lindeman G.J., Visvader J.E. The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity. Journal of Biological Chemistry. 277:2002;7849-7856.
92. Tang, C. K., & Lippman, M. E. (1998). EGF family receptors and their ligands in human cancer. In B. W. O'Malley (Ed.), Hormones and Signaling (pp. 113-165). San Diego, CA: Academic Press.
93. Teglund S., McKay C., Schuetz E., van Deursen J.M., Stravopodis D., Wang D., Brown M., Bodner S., Grosveld G., Ihle J.N. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell. 93:1998;841-850.
94. Tetsu O., McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 398:1999;422-426.
95. Topper Y.J., Freeman C.S. Multiple hormone interactions in the developmental biology of the mammary gland. Physiological Review. 60:1980;1049-1106.
96. Udy G.B., Towers R.P., Snell R.G., Wilkins R.J., Park S.H., Ram P.A., Waxman D.J., Davey H.W. Requirement of Stat5b for sexual dimorphism of body growth rates and liver gene expression. Proceedings of the National Academy of Sciences of United States of America. 94:1997;7239-7244.
97. van Genderen C., Okamura R.M., Farinas I., Quo R.G., Parslow T.G., Bruhn L., Grosschedl R. Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF1-deficient mice. Genes Development. 8:1994;2691-2703.
98. Visvader J.E., Venter D., Hahm K., Santamaria M., Sum E.Y., O'Reilly L., White D., Williams R., Armes J., Lindeman G.J. The LIM domain gene LMO4 inhibits differentiation of mammary epithelial cells in vitro and is overexpressed in breast cancer. Proceedings of the National Academy of Sciences of United States of America. 98:2001;14452-14457.
99. Wang T.C., Cardiff R.D., Zukerberg L., Lees E., Arnold A., Schmidt E.V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature. 369:1994;669-671.
100. Watson C.J., Miller W.R. Elevated levels of members of the Stat family of transcription factors in breast carcinoma nuclear extracts. British Journal of Cancer. 71:1995;840-844.
101. Watson C.J. Stat transcription factors in mammary gland development and tumorigenesis. Journal of Mammary Gland Biological Neoplasia. 6:2001;115-127.
102. Weintraub H., Davis R., Tapscott S., Thayer M., Krause M., Benezra R., Blackwell T.K., Turner D., Rupp R., Hollenberg S.et al. The MyoD gene family: nodal point during specification of the muscle cell lineage. Science. 251:1991;761-766.
103. Wen X., Lin H.H., Shih H.M., Kung H.J., Ann D.K. Kinase activation of the non-receptor tyrosine kinase Etk/BMX alone is sufficient to transactivate Stat-mediated gene expression in salivary and lung epithelial cells. Journal of Biological Chemistry. 274:1999;38204-38210.
104. Xing X., Wang S.C., Xia W., Zou Y., Shao R., Kwong K.Y., Yu Z., Zhang S., Miller S., Huang L., Hung M.C. The Ets protein PEA3 suppresses Her-2/neu overexpression and inhibits tumorigenesis. Natural Medicine. 6:2000;189-195.
105. Xu J., Qiu Y., DeMayo F.J., Tsai S.Y., Tsai M.J., O'Malley B.W. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science. 279:1998;1922-1925.
106. Xu J., Liao L., Ning G., Yoshida-Komiya H., Deng C., O'Malley B.W. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proceedings of the National Academy of Sciences of United States of America. 97:2000;6379-6384.